Drugs / pottasium phosphate
last change Mar 2021 re-read 2 minutes ago

pottasium phosphate

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02746432 Background Jan 2018 → Mar 2021 colon carcinoma King Saud University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as pottasium phosphate “an Infusion of dextrose 20% supplemented with pottasium phosphate (30 mmol/L ) to be administered.” NCT02746432